Concepedia

C. Tallant

CT

Statistics

Publications

39

Citations

3.3K

H-Index

31

Active since

2006

Affiliations

University of Oxford(Current)

Goethe University Frankfurt

Jenner Institute

Genomics (United Kingdom)

Genomics England

C. Tallant is an author at University of Oxford specializing in bromodomain proteins, drug discovery, and bromodomain inhibition.

ORCID

Publications per year

2006–2022

39

Publications

39

Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains

Duncan A. Hay, Oleg Fedorov, Sarah Martin et al. · Journal of the American Chemical Society · 2014 · 285 citations · Full text

, , +17

CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses

Ariane Hammitzsch, C. Tallant, O. Fedorov et al. · Proceedings of the National Academy of Sciences · 2015 · 256 citations · Full text

, , +17

Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor

Laetitia J. Martin, Manfred Koegl, Gerd Bader et al. · Journal of Medicinal Chemistry · 2016 · 224 citations · Full text

, , +13

LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor

Peter G. K. Clark, Lucas Campos Curcino Vieira, C. Tallant et al. · Angewandte Chemie International Edition · 2015 · 164 citations · Full text

, , +15

Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B

Peiling Chen, A. Chaikuad, Paul Bamborough et al. · Journal of Medicinal Chemistry · 2015 · 161 citations · Full text

, , +15

1–5 of 39